Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2003 1
2004 1
2005 5
2006 2
2007 1
2008 1
2009 3
2010 3
2011 3
2012 5
2013 3
2014 1
2015 4
2016 3
2017 3
2018 4
2019 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jjm. Clin Cancer Res. 2017 Aug 15;23(16):4617-4624. doi: 10.1158/1078-0432.CCR-16-2743. Epub 2017 Apr 20. Clin Cancer Res. 2017. PMID: 28428192
Clinical Pharmacology of Radiotheranostics in Oncology.
Te Beek ET, Burggraaf J, Teunissen JJM, Vriens D. Te Beek ET, et al. Among authors: teunissen jjm. Clin Pharmacol Ther. 2023 Feb;113(2):260-274. doi: 10.1002/cpt.2598. Epub 2022 May 10. Clin Pharmacol Ther. 2023. PMID: 35373336 Review.
Nuclear Medicine Imaging of Neuroendocrine Tumors.
Brabander T, Kwekkeboom DJ, Feelders RA, Brouwers AH, Teunissen JJ. Brabander T, et al. Among authors: teunissen jj. Front Horm Res. 2015;44:73-87. doi: 10.1159/000382059. Epub 2015 Aug 14. Front Horm Res. 2015. PMID: 26303705 Review.
Peptide receptor radionuclide therapy of neuroendocrine tumours.
Brabander T, Teunissen JJ, Van Eijck CH, Franssen GJ, Feelders RA, de Herder WW, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jj. Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):103-14. doi: 10.1016/j.beem.2015.10.005. Epub 2015 Oct 8. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971847 Review.
Lutetium-labelled peptides for therapy of neuroendocrine tumours.
Kam BL, Teunissen JJ, Krenning EP, de Herder WW, Khan S, van Vliet EI, Kwekkeboom DJ. Kam BL, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1(Suppl 1):S103-12. doi: 10.1007/s00259-011-2039-y. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388631 Free PMC article. Review.
Precision medicine and theranostics using radiopharmaceuticals in oncology.
Te Beek ET, Teunissen JJM, Postema JWA, Lafeber A, Ten Broek MRJ. Te Beek ET, et al. Among authors: teunissen jjm. Br J Clin Pharmacol. 2022 Jan;88(1):359-361. doi: 10.1111/bcp.14942. Epub 2021 Jun 22. Br J Clin Pharmacol. 2022. PMID: 34159632 Free article. No abstract available.
Preclinical and clinical studies of peptide receptor radionuclide therapy.
Pool SE, Krenning EP, Koning GA, van Eijck CH, Teunissen JJ, Kam B, Valkema R, Kwekkeboom DJ, de Jong M. Pool SE, et al. Among authors: teunissen jj. Semin Nucl Med. 2010 May;40(3):209-18. doi: 10.1053/j.semnuclmed.2009.12.001. Semin Nucl Med. 2010. PMID: 20350630 Review.
43 results